Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Kezar Life Sciences is a clinical-stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address unmet needs in autoimmunity and oncology. The company focuses on pioneering treatments by targeting protein homeostasis pathways, specifically the immunoproteasome and the Sec61 translocon. Their lead product candidate, zetomipzomib (KZR-616), is being evaluated for various autoimmune diseases, while KZR-261 is an investigational agent for solid tumors.
The headquarters serves as the central hub for corporate operations, research and development activities, clinical trial management, and strategic planning.
Located within a prominent life sciences campus, offering modern laboratory and office facilities conducive to biopharmaceutical research and development.
The work culture at Kezar Life Sciences is characterized by innovation, scientific rigor, collaboration, and a strong focus on addressing patient needs. Employees are typically driven by the mission to develop impactful therapies.
Its location in South San Francisco provides strategic advantages, including access to a rich talent pool, research institutions, and a vibrant biotech ecosystem, fostering collaboration and innovation.
While Kezar Life Sciences is headquartered in the United States, its operational reach extends globally, primarily through the conduct of clinical trials. The company collaborates with research institutions, investigators, and clinical sites in North America, Europe, and potentially other regions to advance its therapeutic programs for autoimmune diseases and cancer.
One South San Francisco Drive, Suite 210
South San Francisco
CA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Kezar Life Sciences' leadership includes:
Kezar Life Sciences has been backed by several prominent investors over the years, including:
In the past 12 months, Kezar Life Sciences saw a key transition in its finance leadership, with the appointment of a new Chief Financial Officer in November 2023.
Discover the tools Kezar Life Sciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Kezar Life Sciences primarily utilizes the email format combining the first initial of an employee's name followed by their last name.
[first_initial][last]@kezarlifesciences.com
Format
jfowler@kezarlifesciences.com
Example
80%
Success rate
GlobeNewswire (Kezar Life Sciences Press Release) • May 9, 2024
Kezar reported its financial results for the first quarter of 2024, highlighting progress in its KZR-261 and zetomipzomib clinical programs, and outlined upcoming milestones for its pipeline....more
GlobeNewswire (Kezar Life Sciences Press Release) • March 7, 2024
Kezar announced its fourth quarter and full-year 2023 financial results, detailing significant advancements in its clinical pipeline and strategic objectives for 2024, including updates on zetomipzomib and KZR-261....more
GlobeNewswire (Kezar Life Sciences Press Release) • November 2, 2023
Kezar announced the appointment of Marc L. Belsky as its new Chief Financial Officer, succeeding Celia Economides. Mr. Belsky brings over 20 years of financial leadership experience in the biopharmaceutical industry....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Kezar Life Sciences, are just a search away.